Wayne Godfrey
Keine laufenden Positionen mehr
Vermögen: 110 729 $ am 31.03.2024
Profil
Wayne Godfrey worked as a Senior Director in Clinical Research Oncology at Gilead Sciences, Inc. from 2012 to 2015.
He then worked as a Chief Medical Officer at Etubics Corp.
in 2015-2016.
In 2017-2018, he worked as a Senior Director in Clinical Development at Kite Pharma, Inc. Later, he worked as a Vice President in Clinical Development at Bavarian Nordic, Inc. and IGM Biosciences, Inc. respectively.
Currently, he is working as a Chief Medical Officer at Janux Therapeutics, Inc. Dr. Godfrey completed his undergraduate degree from the University of California, Santa Barbara, his graduate degree from Stanford University, and his doctorate from Washington University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
JANUX THERAPEUTICS, INC.
0,01% | 15.02.2023 | 2 941 ( 0,01% ) | 110 729 $ | 31.03.2024 |
Ehemalige bekannte Positionen von Wayne Godfrey
| Unternehmen | Position | Ende |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 05.07.2023 |
| KITE PHARMA INC | Chief Tech/Sci/R&D Officer | 01.01.2018 |
Etubics Corp.
 Etubics Corp. BiotechnologyHealth Technology Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA. | Chief Tech/Sci/R&D Officer | 01.01.2016 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01.01.2015 |
Bavarian Nordic, Inc.
 Bavarian Nordic, Inc. Miscellaneous Commercial ServicesCommercial Services Bavarian Nordic, Inc. engages in researching and manufacturing drugs to treat cancer. The company is headquartered in Morrisville, NC. | Corporate Officer/Principal | - |
Ausbildung von Wayne Godfrey
| Stanford University | Graduate Degree |
| University of California, Santa Barbara | Undergraduate Degree |
| Washington University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| IGM BIOSCIENCES, INC. | Health Technology |
| JANUX THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Bavarian Nordic, Inc.
Bavarian Nordic, Inc. Miscellaneous Commercial ServicesCommercial Services Bavarian Nordic, Inc. engages in researching and manufacturing drugs to treat cancer. The company is headquartered in Morrisville, NC. | Commercial Services |
Etubics Corp.
Etubics Corp. BiotechnologyHealth Technology Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA. | Health Technology |
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
